Ju‐Chuan Hu
Papers
5
Total Citations
122
H-Index
5
About
Dr. Ju-Chuan Hu is a leading urologic oncologist whose research focuses on advancing surgical techniques and genetic risk stratification for prostate cancer. He is best known for pioneering work on Retzius-sparing robotic-assisted radical prostatectomy (RARP), demonstrating that this approach significantly improves early urinary continence outcomes by reducing bladder neck descent—findings supported by his most-cited paper (74 citations). Dr. Hu has also explored the interplay between neurovascular bundle preservation and continence recovery, refining surgical protocols to enhance patient quality of life without compromising oncologic safety. Beyond the operating room, his investigations into long noncoding RNA polymorphisms—specifically MALAT1 and H19—have uncovered genetic markers associated with lymph node metastasis and aggressive disease features, offering potential tools for better risk stratification in intermediate- and high-risk prostate cancer. His work on neoadjuvant hormone therapy followed by RARP has further informed treatment sequencing for advanced cases. With a portfolio of impactful studies and a commitment to translating molecular insights into clinical practice, Dr. Hu continues to shape the future of prostate cancer management, bridging surgical innovation with precision oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5